2013Medical Journal of CommunicationsRequires access

Clinical study on best dosage of continuous intravenous remifentanil combined with propofol for anesthetic induction and tracheal intubation

Qing Li

Open publisher page 0 citations

Abstract

Objective:To investigate the best dosage of continuous intravenous remifentanil combined with propofol for anesthetic induction and tracheal intubation.Methods:Eighty ASA Ⅰ ~ Ⅱ patients were randomly allocated to one of four groups of 20 each:group A,B,C and D.Anaesthesia was induced with remifentanil 0.4,0.5,0.6 or 0.7μg.kg-1.min-1 for group A,B,C and D,respectively.Each patient was administered 1.5 mg.kg-1 propofol 2 min after the start of remifentanil infusion,and 0.6 mg.kg-1 rocuronium 1.5 min after propofol injection.Tracheal intubation was performed 1.5 min after rocuronium injection,and each patient was administered 0.1μg.kg-1.min-1 remifentanil and 4 mg.kg-1.h-1 propofol at this time point.Noninvasive blood pressure and heart rate were recorded before anesthetic induction(T1),immediately before intubation(T2),immediately after intubation(T3),1 min after intubation(T4),2 min after intubation(T5),3 min after intubation(T6),4 min after intubation(T7),and 5 min after intubation(T8).The adverse effects like cough and muscle rigidity and use of vasoactive agents were also recorded.Results:MAP and HR decreased in all groups at T2(P0.05),and HR was lower in group D than in group A at this time point(P0.05).After intubation,MAP and HR increased immediately and were higher compared with the baseline value till T5 in group A(P0.05).There was no difference in MAP and HR compared with the baseline value after intubation in group B and C(P0.05).MAP remained below the baseline value after intubation till T8 in group D(P0.05).There were more patients needing vasoactive agents in group A and D than in group B and C(P0.05).No patient among the four groups presented with cough and muscle rigidity.Conclusion:Continuous intravenous remifentanil for 5 min produced a dose-related attenuation of the haemodynamic response to tracheal intubation without adverse effects like cough and muscle rigidity,and remifentanil 0.5-0.6μg.kg-1.min-1 combined with 1.5 mg.kg-1 propofol maintained more stable hemodynamics.

About this research paper

What this paper is about

Objective:To investigate the best dosage of continuous intravenous remifentanil combined with propofol for anesthetic induction and tracheal intubation.Methods:Eighty ASA Ⅰ ~ Ⅱ patients were randomly allocated to one of four groups of 20 each:group A,B,C and D.Anaesthesia was induced with remifentanil 0.4,0.5,0.6 or 0.7μg.kg-1.min-1 for group A,B,C and D,respectively.Each patient was administered 1.5 mg.kg-1 propofol 2 min after the start of remifentanil infusion,and 0.6 mg.kg-1 rocuronium 1.5 min after propofol injection.Tracheal intubation was performed 1.5 min after rocuronium injection,and each patient was administered 0.1μg.kg-1.min-1 remifentanil and 4 mg.kg-1.h-1 propofol at this time point.Noninvasive blood pressure and heart rate were recorded before anesthetic induction(T1),immediately before intubation(T2),immediately after intubation(T3),1 min after intubation(T4),2 min after intubation(T5),3 min after intubation(T6),4 min after intubation(T7),and 5 min after intubation(T8).The adverse effects like cough and muscle rigidity and use of vasoactive agents were also recorded.Results:MAP and HR decreased in all groups at T2(P0.05),and HR was lower in group D than in group A at this time point(P0.05).After intubation,MAP and HR increased immediately and were higher compared with the baseline value till T5 in group A(P0.05).There was no difference in MAP and HR compared with the baseline value after intubation in group B and C(P0.05).MAP remained below the baseline value after intubation till T8 in group D(P0.05).There were more patients needing vasoactive agents in group A and D than in group B and C(P0.05).No patient among the four groups presented with cough and muscle rigidity.Conclusion:Continuous intravenous remifentanil for 5 min produced a dose-related attenuation of the haemodynamic response to tracheal intubation without adverse effects like cough and muscle rigidity,and remifentanil 0.5-0.6μg.kg-1.min-1 combined with 1.5 mg.kg-1 propofol maintained more stable hemodynamics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the best dosage of continuous intravenous remifentanil combined with propofol for anesthetic induction and tracheal intubation.Methods:Eighty ASA Ⅰ ~ Ⅱ patients were randomly allocated to one of four groups of 20 each:group A,B,C and D.Anaesthesia was induced with remifentanil 0.4,0.5,0.6 or 0.7μg.kg-1.min-1 for group A,B,C and D,respectively.Each patient was administered 1.5 mg.kg-1 propofol 2 min after the start of remifentanil infusion,and 0.6 mg.kg-1 rocuronium 1.5 min after propofol injection.Tracheal intubation was performed 1.5 min after rocuronium injection,and each patient was administered 0.1μg.kg-1.min-1 remifentanil and 4 mg.kg-1.h-1 propofol at this time point.Noninvasive blood pressure and heart rate were recorded before anesthetic induction(T1),immediately before intubation(T2),immediately after intubation(T3),1 min after intubation(T4),2 min after intubation(T5),3 min after intubation(T6),4 min after intubation(T7),and 5 min after intubation(T8).The adverse effects like cough and muscle rigidity and use of vasoactive agents were also recorded.Results:MAP and HR decreased in all groups at T2(P0.05),and HR was lower in group D than in group A at this time point(P0.05).After intubation,MAP and HR increased immediately and were higher compared with the baseline value till T5 in group A(P0.05).There was no difference in MAP and HR compared with the baseline value after intubation in group B and C(P0.05).MAP remained below the baseline value after intubation till T8 in group D(P0.05).There were more patients needing vasoactive agents in group A and D than in group B and C(P0.05).No patient among the four groups presented with cough and muscle rigidity.Conclusion:Continuous intravenous remifentanil for 5 min produced a dose-related attenuation of the haemodynamic response to tracheal intubation without adverse effects like cough and muscle rigidity,and remifentanil 0.5-0.6μg.kg-1.min-1 combined with 1.5 mg.kg-1 propofol maintained more stable hemodynamics.

Key concepts: Remifentanil, Rocuronium, Propofol, Intubation, Anesthesia, Medicine, Tracheal intubation, Anesthetic

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study on best dosage of continuous intravenous remifentanil combined with propofol for anesthetic induction and tracheal intubation — Research Paper | ScholarLens